WA
TARS icon

WPG Advisers’s Tarsus Pharmaceuticals TARS Stock Holding History

WPG Advisers’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$629 Hold
10
– – ﹤0.01% 1411
2026
Q1 		$702 Sell
10
-7
-41% -$489 ﹤0.01% 1310
2025
Q4 		$1.39K Buy
+17
New +$1.27K ﹤0.01% 1223
2025
Q1 		– Sell
-9
Closed -$498 – 1531
2024
Q4 		$498 Buy
+9
New +$409 ﹤0.01% 1342

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

WPG Advisers's TARS Position: Q2 2026 in Review

WPG Advisers held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 10 shares worth $629. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

WPG Advisers first reported a position in TARS in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.39K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • WPG Advisers held 10 shares of Tarsus Pharmaceuticals worth $629 as of Q2 2026.
  • WPG Advisers left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1411 holding.
  • WPG Advisers first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • WPG Advisers's Tarsus Pharmaceuticals position peaked at $1.39K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.